Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Asset Utilization Ratio (2020 - 2024)

Benitec Biopharma has reported Asset Utilization Ratio over the past 5 years, most recently at 0.0 for Q1 2024.

  • Quarterly results put Asset Utilization Ratio at 0.0 for Q1 2024, down 94.3% from a year ago — trailing twelve months through Mar 2024 was 0.0 (down 94.3% YoY), and the annual figure for FY2023 was 0.01, up 169.25%.
  • Asset Utilization Ratio reached 0.0 in Q1 2024 per BNTC's latest filing, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.01 in Q3 2020 and bottomed at 0.0 in Q3 2021.
  • Median Asset Utilization Ratio over the past 5 years was 0.0 (2022), compared with a mean of 0.0.
  • The largest annual shift saw Asset Utilization Ratio tumbled 98.33% in 2021 before it soared 2871.08% in 2022.
  • Over 5 years, Asset Utilization Ratio stood at 0.0 in 2020, then tumbled by 56.17% to 0.0 in 2021, then skyrocketed by 134.93% to 0.0 in 2022, then plummeted by 38.98% to 0.0 in 2023, then plummeted by 84.72% to 0.0 in 2024.
  • Business Quant data shows Asset Utilization Ratio for BNTC at 0.0 in Q1 2024, 0.0 in Q4 2023, and 0.0 in Q3 2023.